U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H21N5O2
Molecular Weight 375.4237
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GBLD-345

SMILES

COC1=C(N=C2C=CC(NCC3=CC(OC)=CC=C3)=NN12)C4=CC=C(N)C=C4

InChI

InChIKey=HQRHGSRWOHGIRI-UHFFFAOYSA-N
InChI=1S/C21H21N5O2/c1-27-17-5-3-4-14(12-17)13-23-18-10-11-19-24-20(21(28-2)26(19)25-18)15-6-8-16(22)9-7-15/h3-12H,13,22H2,1-2H3,(H,23,25)

HIDE SMILES / InChI

Molecular Formula C21H21N5O2
Molecular Weight 375.4237
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
1.0 nM [IC50]
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:34:04 GMT 2023
Edited
by admin
on Sat Dec 16 17:34:04 GMT 2023
Record UNII
VW8QLT5H8X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GBLD-345
Code English
Imidazo[1,2-b]pyridazin-6-amine, 2-(4-aminophenyl)-3-methoxy-N-[(3-methoxyphenyl)methyl]-
Systematic Name English
GBLD345
Code English
2-(4-AMINOPHENYL)-3-METHOXY-N-((3-METHOXYPHENYL)METHYL)IMIDAZO(1,2-B)PYRIDAZIN-6-AMINE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID301028519
Created by admin on Sat Dec 16 17:34:04 GMT 2023 , Edited by admin on Sat Dec 16 17:34:04 GMT 2023
PRIMARY
CAS
122479-08-7
Created by admin on Sat Dec 16 17:34:04 GMT 2023 , Edited by admin on Sat Dec 16 17:34:04 GMT 2023
PRIMARY
WIKIPEDIA
GBLD-345
Created by admin on Sat Dec 16 17:34:04 GMT 2023 , Edited by admin on Sat Dec 16 17:34:04 GMT 2023
PRIMARY
PUBCHEM
4602899
Created by admin on Sat Dec 16 17:34:04 GMT 2023 , Edited by admin on Sat Dec 16 17:34:04 GMT 2023
PRIMARY
FDA UNII
VW8QLT5H8X
Created by admin on Sat Dec 16 17:34:04 GMT 2023 , Edited by admin on Sat Dec 16 17:34:04 GMT 2023
PRIMARY